DE602006010702D1 - Homomorpholinoxazolidinone als antibakterielle mittel - Google Patents

Homomorpholinoxazolidinone als antibakterielle mittel

Info

Publication number
DE602006010702D1
DE602006010702D1 DE602006010702T DE602006010702T DE602006010702D1 DE 602006010702 D1 DE602006010702 D1 DE 602006010702D1 DE 602006010702 T DE602006010702 T DE 602006010702T DE 602006010702 T DE602006010702 T DE 602006010702T DE 602006010702 D1 DE602006010702 D1 DE 602006010702D1
Authority
DE
Germany
Prior art keywords
sup
sub
homomorpholinoxazolidinone
antibacterial agent
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010702T
Other languages
German (de)
English (en)
Inventor
Vara Prasad Venkata Nagendra Josyula
Frederick Earl Boyer Jr
Ji-Young Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Publication of DE602006010702D1 publication Critical patent/DE602006010702D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE602006010702T 2005-06-29 2006-06-20 Homomorpholinoxazolidinone als antibakterielle mittel Active DE602006010702D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69486205P 2005-06-29 2005-06-29
PCT/IB2006/001730 WO2007000644A1 (en) 2005-06-29 2006-06-20 Homomorpholine oxazolidinones as antibacterial agents

Publications (1)

Publication Number Publication Date
DE602006010702D1 true DE602006010702D1 (de) 2010-01-07

Family

ID=37101665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010702T Active DE602006010702D1 (de) 2005-06-29 2006-06-20 Homomorpholinoxazolidinone als antibakterielle mittel

Country Status (8)

Country Link
EP (1) EP1899331B1 (enExample)
JP (1) JP2008544979A (enExample)
AT (1) ATE449773T1 (enExample)
CA (1) CA2610978A1 (enExample)
DE (1) DE602006010702D1 (enExample)
DK (1) DK1899331T3 (enExample)
ES (1) ES2335307T3 (enExample)
WO (1) WO2007000644A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101460495B (zh) 2006-03-31 2013-08-14 财团法人乙卯研究所 具有杂环的化合物
JP5455906B2 (ja) * 2007-08-06 2014-03-26 ミクウルク ファーマシューティカルズ,インコーポレイテッド 細菌感染症治療のための抗微生物性オルト−フルオロフェニルオキサゾリジノン
EP2669283A1 (en) * 2007-10-02 2013-12-04 Shionogi&Co., Ltd. Oxazolidinone derivative having 7-membered hetero ring
CA2939098A1 (en) 2014-02-21 2015-08-27 Micurx Pharmaceuticals, Inc. Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration
CN113603683B (zh) * 2015-07-17 2024-06-14 结核病药物开发全球联盟公司 用于抗微生物治疗的经取代苯基噁唑烷酮

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5952324A (en) 1994-11-15 1999-09-14 Pharmacia & Upjohn Company Bicyclic oxazine and thiazine oxazolidinone antibacterials
CN1154644C (zh) 1997-11-12 2004-06-23 法玛西雅厄普约翰美国公司 噁唑烷酮衍生物和药物组合物
JP2000204084A (ja) 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
HK1040707A1 (zh) 1998-11-27 2002-06-21 法玛西雅厄普约翰美国公司 具有硫代羰基官能團的噁唑烷酮抗菌劑
US6297242B1 (en) 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
SK7572002A3 (en) 1999-12-21 2002-12-03 Upjohn Co Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents
AU2001253113B2 (en) 2000-04-20 2005-02-03 Pharmacia & Upjohn Company Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
ATE301474T1 (de) 2000-06-30 2005-08-15 Pharmacia & Upjohn Co Llc Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten
GB0017225D0 (en) 2000-07-14 2000-08-30 Really Useful Products Limited Container
DE10034627A1 (de) 2000-07-17 2002-01-31 Bayer Ag Aryl-substituierte Oxazolidinone mit Cytokin inhibitorischer Wirkung
HUP0302918A2 (hu) 2000-07-17 2003-12-29 Ranbaxy Laboratories Limited Mikrobaellenes oxazolidinonszármazékok és a vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
DE60144522D1 (de) 2000-08-24 2011-06-09 Sirf Tech Inc Vorrichtung zur reduzierung von autokorrelation und kreuzkorrelation bei schwachen cdma-signalen
PE20020578A1 (es) 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
US20030008012A1 (en) 2001-02-05 2003-01-09 Pena Lorraine E. Composition for rectal delivery of an oxazolidinone antibacterial drug
DE10105989A1 (de) 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ES2268011T3 (es) 2001-04-07 2007-03-16 Astrazeneca Ab Oxazolidinonas que contienen un grupo sulfonimida como antibioticos.
GB0108793D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
EP1409464A4 (en) 2001-07-16 2005-11-02 Ranbaxy Lab Ltd OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS
US6956040B2 (en) 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
TW200302095A (en) 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
TW200400055A (en) 2002-02-22 2004-01-01 Pharmacia Corp Ophthalmic formulation with novel gum composition
WO2003072141A1 (en) 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
KR20040086465A (ko) 2002-02-28 2004-10-08 아스트라제네카 아베 화합물
AU2003207340A1 (en) 2002-02-28 2003-09-09 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
EP1490059A1 (en) 2002-03-29 2004-12-29 Pharmacia & Upjohn Company LLC Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
AU2003224345A1 (en) 2002-04-30 2003-11-17 Orchid Chemicals & Pharmaceuticals Antibacterial agents
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
WO2004009587A1 (en) 2002-07-22 2004-01-29 Orchid Chemicals & Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial agents
EA200500283A1 (ru) 2002-07-29 2005-08-25 Рэнбакси Лабораториз Лимитед Производные оксазолидинона как противомикробные средства
AU2003253141A1 (en) 2002-08-22 2004-03-11 Orchid Chemicals And Pharmaceuticals Ltd Novel antibacterial agents

Also Published As

Publication number Publication date
DK1899331T3 (da) 2010-03-08
JP2008544979A (ja) 2008-12-11
ES2335307T3 (es) 2010-03-24
WO2007000644A1 (en) 2007-01-04
CA2610978A1 (en) 2007-01-04
EP1899331B1 (en) 2009-11-25
ATE449773T1 (de) 2009-12-15
EP1899331A1 (en) 2008-03-19

Similar Documents

Publication Publication Date Title
MEP8409A (en) Fused heterocyclic compound
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
NO20070532L (no) Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
ATE454152T1 (de) 2-aminopyrimidin-derivate als raf-kinase-hemmer
AP1902A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
NO20023097D0 (no) Heterocykliske forbindelser med sulfonamidgrupper
WO2008114819A1 (ja) 新規アデニン化合物
ATE556058T1 (de) 1-(2h)-isochinolonderivat
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
ITMI20041566A1 (it) "trpv1 agonisti, formulazioni che li contengono e loro usi"
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
CA2655527C (en) Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
ATE417841T1 (de) Furanderivate als ep4-rezeptorantagonisten
EP1961734A4 (en) AMINE CONNECTION AND ITS USE FOR MEDICAL PURPOSES
DK1447400T3 (da) Bicyklisk forbindelse
ATE519818T1 (de) Reversibel thermochrome zusammensetzung
DE602006010702D1 (de) Homomorpholinoxazolidinone als antibakterielle mittel
NO20050871L (no) 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer
ATE443046T1 (de) Organische verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition